U.S. used car auction prices held steady in August, but long-term tariff effects on new car costs signal potential price increases. Market watchers should track these inflation and trade-driven dynamics.

Pharmaceutical import tariffs are driving up health insurance premiums in the ACA small group market, as insurers anticipate higher drug costs and incorporate these risks into rate filings. This impacts employer health benefits and premium affordability.

Increasing tariffs on auto parts raise automobile insurance premiums, encouraging growth in affordable, low-cost e-bike transportation alternatives and related insurance trends.

Stay informed on the latest market developments including tariff continuation, OPEC+ output changes, and labor official changes impacting the economic landscape relevant to U.S. insurance professionals.

Swiss Re's latest sigma study projects slower global insurance premium growth and economic expansion due to increased US tariffs, with the US market most affected.

Tariffs on medical imports have led U.S. health plans to plan premium increases for 2025 due to rising drug and device costs, impacting payer pricing strategies and market outlooks.

Explore how Trump administration cuts to NIH funding, public health grants, and potential Medicaid changes disrupt U.S. health care research, public health efforts, and patient care access.

Policy unpredictability, rising insurance and tax costs, and trade tensions are slowing the U.S. housing market recovery in 2019, creating cautious consumer behavior and a weak summer buying season outlook.

Explore how Georgia's tort reform, manufacturing tariffs, automotive regulations, and AI advancements are shaping the U.S. insurance industry landscape in 2024.

U.S. property/casualty insurance posts strongest underwriting results since 2013 with improved combined ratios and premium growth; 2025 outlook tempered by wildfire losses and tariff impacts on costs.